Oragenics Inc (OGEN) stock

OGENNYSEPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 1/30

$0.20−0.15 (-42.59%)

Close on Nov 13, 2026Market cap $906.90KP/E –Yield –

Oragenics price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Oragenics's price to sales ratio was 461.1× on Oct 31, 2012, against 440.3× a year earlier.

Period	Period end	Value	Change (pts)
2012	Oct 31, 2012	461.1×	+328.7
2011	Dec 30, 2011	132.3×	–

See a number that looks wrong?